NCT07591922 Intraoperative Music Therapy in TAVR Patients
| NCT ID | NCT07591922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rhode Island Hospital |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-05-26 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-05-26 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effect of intraoperative music on patient anxiety and comfort during transcatheter aortic valve replacement (TAVR) procedures.
Eligibility Criteria
Inclusion Criteria: * Scheduled to undergo elective transfemoral TAVR under MAC (Monitored Anesthesia Care) at Rhode Island Hospital * Able to answer questions about anxiety Exclusion Criteria: * Transfemoral TAVR procedures requiring general anesthesia * Emergent TAVR procedures * Significant hearing impairment that would preclude ability to hear music via headphones * Documented severe claustrophobia or inability to tolerate headphones * Inability to complete questionnaires * Inability or unwillingness to provide informed consent
Contact & Investigator
Shyamal Asher, MD
PRINCIPAL INVESTIGATOR
Brown University Health
Frequently Asked Questions
Who can join the NCT07591922 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07591922 currently recruiting?
Yes, NCT07591922 is actively recruiting participants. Contact the research team at SAsher@brownhealth.org for enrollment information.
Where is the NCT07591922 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT07591922 clinical trial?
NCT07591922 is sponsored by Rhode Island Hospital. The principal investigator is Shyamal Asher, MD at Brown University Health. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.